Diamondback 360° Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Lesions: 2-Year Results of the Pivotal ORBIT II Trial - Jeffrey W. Chambers, MD

↳ This is a section part of Moment: CRT 2015 Coronary - The iMPACT Trials: Session I

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$25.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Diamondback 360° Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Lesions: 2-Year Results of the Pivotal ORBIT II Trial presented by Jeffrey W. Chambers, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$25.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: The iMPACT Trials: Session I

Track: Coronary

Learning Objectives

Update in advances in Complex Coronary Intervention

Other Components in this Moment

Overview

EVEREST II REALISM - A Continued Access Study to Evaluate the Safety and Effectiveness of the MitraClip Device: Demographics and Procedural Outcomes - Laura Mauri, MD

Two Year Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) - Michael Haude, MD, PhD

Diamondback 360° Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Lesions: 2-Year Results of the Pivotal ORBIT II Trial - Jeffrey W. Chambers, MD

Commentary on iMPACT Trials - Stephan Windecker, MD

Live Case Demonstration from Mount Sinai Medical Center - New York, NY

Keynote Lecture: the Five Best Trials from 2014 That May iMPACT My Practice - David R. Holmes Jr., MD

IVUS, NIRS and OCT: Which Should We Use and When? - Carlo Di Mario, MD

LM Coronary Stenting State of the Field: What Are We Doing in Europe? - Marie-Claude Morice, MD

Predicting the EXCEL Results From the SYNTAX Score II - P. Serruys, MD, PhD

Escalation in Hemodynamic Support - John M. Lasala, MD, PhD

Radial vs. Femoral Access in ACS Patients - Michael J. Cowley, MD

Live Case Demonstration From MedStar Washington Hospital Center - Washington, DC